Fortress Biotech (FBIO) Gross Margin Growth (1y) (2016 - 2026)
Powered by 
Analysis
Fortress Biotech (FBIO) Gross Margin Growth (1y) (2016 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn | -93.00 |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn | -91.00 |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn | 210.00 |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn | 1,966.00 |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - | - |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn | 228.00 |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn | -475.00 |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | - |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | 1,034.00 |
| 10 | Fortress Biotech | 86.15 Mn | -110.42 Mn | 12.58 Mn | -273.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -273.00 |
| Dec 31, 2025 | -288.00 |
| Sep 30, 2025 | -208.00 |
| Jun 30, 2025 | 835.00 |
| Mar 31, 2025 | 961.00 |
| Dec 31, 2024 | -1,968.00 |
| Sep 30, 2024 | -1,206.00 |
| Jun 30, 2024 | 623.00 |
| Mar 31, 2024 | 582.00 |
| Dec 31, 2023 | 3,578.00 |
| Sep 30, 2023 | 2,519.00 |
| Jun 30, 2023 | -281.00 |
| Mar 31, 2023 | -1,760.00 |
| Dec 31, 2022 | 507.00 |
| Sep 30, 2022 | 927.00 |
| Jun 30, 2022 | 8.00 |
| Mar 31, 2022 | -56.00 |
| Dec 31, 2021 | -2,098.00 |
| Sep 30, 2021 | -1,730.00 |
| Jun 30, 2021 | -891.00 |